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A B S T R A C T
Insomnia has been shown to contribute to the development of psychotic experiences, predominantly via in-
creasing negative aﬀect. However, the role of insomnia in the persistence of psychotic experiences is yet to be
investigated in a clinical population. Furthermore, other plausible inﬂuences, such as psychotic experiences
contributing to insomnia, remain to be evaluated. This study tests the role of insomnia as a predictor of per-
sistence of psychotic experiences versus other potential causal routes. Twenty-nine patients aged 18–30 with
non-aﬀective psychosis completed three assessments over three months of their insomnia, negative aﬀect, and
psychotic experiences. Mixed eﬀect models allowed comparisons between hypothesis-based models (comprising
insomnia as predictor, negative aﬀect as mediator, and psychotic experiences as outcome) and oppositional
models, where relationships were reversed. The results supported the hypothesised mediation model above
models where negative aﬀect was primary. Insomnia was also found to be a stronger predictor of later hallu-
cinations than vice versa, although a bidirectional relationship was indicated between insomnia and paranoia. In
conclusion, insomnia predicts persistence of psychotic experiences over time to the same or greater extent than
psychotic experiences contribute to insomnia. This supports insomnia as a potential intervention target in
psychosis.
1. Introduction
Insomnia has traditionally been thought of as a consequence of
psychotic symptoms, however recent research indicates that insomnia
itself contributes to the development of psychotic experiences
(Reeve et al., 2015). For example, an experimental study found that
inducing insomnia-like sleep loss in non-clinical volunteers resulted in
increased paranoia and hallucinations (Reeve et al., 2018), and a large
clinical trial of an online CBT intervention for insomnia in students
found that treating insomnia reduced subclinical paranoia and hallu-
cinations (Freeman et al., 2017). Together these ﬁndings demonstrate a
causal role for insomnia in psychosis, implying that insomnia may re-
present a novel target for treatment of psychosis.
Sleep disturbance in general has been increasingly associated with
psychotic experiences in both clinical and non-clinical populations
(Chiu et al., 2016; Davies et al., 2017; Koyanagi and Stickley, 2015) .
However, there is a surprising lack of studies investigating the re-
lationship between insomnia (as a speciﬁc sleep disorder) and psychosis
in individuals with a psychotic disorder (Reeve et al., 2015). Cross-
sectional studies indicate that individuals with psychotic disorders and
comorbid insomnia have more severe psychotic experiences than those
without (Freeman et al., 2009; Xiang et al., 2009). Yet longitudinal
research is currently limited to studies utilising experience sampling
methods (ESM) to collect high frequency data across a short time
period. This technique allows investigation of the interplay between
night-time sleep and day-time mental health, with signiﬁcant re-
lationships reported between lowered sleep quality, eﬃciency, and
duration and increased psychotic experiences the following day
(Hennig and Lincoln, 2018; Mulligan et al., 2016; Waters et al., 2011).
Notably, in one of these studies shorter sleep was found to predict
paranoia (but not the reverse) in a non-clinical adolescent group
(Hennig and Lincoln, 2018).
However, there are limitations to the ESM approach. Firstly, al-
though the results are clearly applicable to insomnia (in which sleep
eﬃciency, quality, and duration are lowered), these studies do not
measure insomnia symptoms directly. Secondly, as assessments are
completed repeatedly within a short time, outcomes are measured using
individual items (or a small set of items), instead of a fully validated
https://doi.org/10.1016/j.psychres.2018.08.090
Received 14 March 2018; Received in revised form 9 July 2018; Accepted 24 August 2018
⁎ Correspondence author.
E-mail address: Sarah.reeve@psych.ox.ac.uk (S. Reeve).
Psychiatry Research 269 (2018) 673–680
Available online 25 August 2018
0165-1781/ © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
questionnaire or interview assessment. Finally, due to the intensity of
the ESM approach the observational period remains short. Therefore, it
remains unclear if the day-by-day relationships found in ESM studies
can be extrapolated to diagnosable insomnia (which requires a duration
of 3 months of symptoms) or psychotic symptoms assessed over longer
time periods. This is of particular importance in early psychosis where
treatment of predictors of psychotic symptoms could improve later
clinical trajectory.
Negative aﬀect – here used as a generic term to refer to depression
and anxiety - is often identiﬁed as a mediator in the insomnia to psy-
chosis relationship (e.g. Reeve et al., 2018, 2015), as supported by a
large literature linking insomnia and aﬀect. Insomnia and depression
are strongly related: individuals with insomnia are at higher risk of
developing depression (Li et al., 2016), and treating insomnia has also
been shown to improve depression (e.g. Christensen et al., 2016). Those
with depression are also more likely to develop insomnia (Jansson-
Fröjmark and Lindblom, 2008). Insomnia and anxiety have a strong, if
less researched relationship. Anxiety is predictive of later insomnia, and
insomnia is similarly predictive of later anxiety (Neckelmann et al.,
2007). The psychological processes shared between cognitive models of
insomnia and anxiety (such as hyperarousal, catastrophising, and in-
trusive thoughts) also link the phenomena (Espie, 1991; Harvey, 2002).
Whilst negative aﬀect has been shown to mediate the relationship be-
tween insomnia and psychosis (Hennig and Lincoln, 2018; Mulligan
et al., 2016; Reeve et al., 2018), the bidirectional relationship between
insomnia and negative aﬀect means that it is equally plausible that
insomnia could mediate the relationship between negative aﬀect and
psychosis (see Fig. 1a for a diagram of these pathways). No previous
study has tested this possibility.
Furthermore, while recent research has focused on demonstrating
the causal role of insomnia in psychotic experiences (Freeman et al.,
2017; Reeve et al., 2018), it also remains likely that psychotic experi-
ences contribute to insomnia (see Fig. 1b). One obvious route would be
that distress from psychotic experiences increases arousal and delays
sleep onset (Waite et al., 2016a). Other possible factors include lowered
daytime activity, which is common in psychosis (Hodgekins et al.,
2015; Stubbs et al., 2016), and can cause sleep disturbance by desta-
bilising circadian rhythms (Waite et al., 2016b). Based on these and
other factors a bidirectional relationship between insomnia and psy-
chosis has been proposed, but not adequately tested (Harvey and
Murray, 2011; Reeve et al., 2015). Whether this relationship is truly
bidirectional is important to assess, since it may have clinical
implications for prioritising treatment of insomnia versus psychotic
experiences.
1.1. The current study
The current study aimed to investigate the interaction between in-
somnia, negative aﬀect (i.e. depression and anxiety), and psychotic
experiences (i.e. paranoia and hallucinations) over several months
within a cohort of individuals with early psychosis. The analytical ap-
proach was to test the directions of eﬀect between insomnia, negative
aﬀect, and psychotic experiences by comparing models derived from
key hypotheses (that insomnia predicts later psychotic experiences,
with negative aﬀect acting as the key mediator) to oppositional models
where key relationships are reversed in order to disentangle the most
relevant causal inﬂuences between these factors. The hypotheses tested
were:
1. Insomnia, negative aﬀect, and psychotic experiences are cross-sec-
tionally associated;
2. Insomnia is predictive of later psychotic experiences;
3. The relationship between insomnia and later psychotic experiences
is mediated by negative aﬀect;
4. Psychotic experiences are predictive of later insomnia;
5. Insomnia is more predictive of later psychotic experiences than
psychotic experiences are of later insomnia.
2. Method
2.1. Recruitment
Twenty-nine participants were recruited for the current study. The
inclusion criteria were: primary diagnosis of non-aﬀective psychotic
disorder; outpatient status; and age between 18 and 30. The age range
was selected to minimise the eﬀects of long-term antipsychotic medi-
cation usage on sleep, and to control for changes in sleep over the
lifespan. Exclusion criteria were: primary diagnosis of aﬀective, sub-
stance abuse, organic, or neurological disorder; and non-ﬂuency in
English. Eligible participants were initially approached by members of
their NHS care team and given information regarding the study. Those
willing to participate provided written informed consent to take part in
the study and received compensation for their time in taking part. The
study received approval from an NHS research ethics committee (South
West-Frenchay REC reference 15/SW/0291), and local approvals were
received for each of the three study sites.
2.2. Design and assessments
In this longitudinal observational study participants were assessed
at baseline, one month, and three months. All measures were completed
at every time point. For all measures higher scores indicate greater
severity of symptomatology.
2.2.1. Insomnia
Insomnia was assessed using the Sleep-50 (Spoormaker et al., 2005),
a self-report questionnaire indexing severity of a number of sleep dis-
orders. The total scale is comprised of 50 statements which are rated for
agreement over the past month, on a 1 (“Not at all”) to 4 (“Very much”)
Likert scale. The subscale for insomnia was used in the current study,
which comprises 8 items, with a minimum score of 8 and a maximum
score of 32. The insomnia subscale demonstrates high consistency
(Cronbach's alpha=0.85)
2.2.2. Psychotic experiences
Paranoia and hallucinations were assessed using the Speciﬁc
Psychotic Experiences Questionnaire (SPEQ; Ronald et al., 2014). The
SPEQ is a self-report questionnaire with dimensions for individual
Fig. 1. Possible pathways between insomnia, negative aﬀect, and psychotic
experiences.
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psychotic experiences, of which the subscales for paranoia and hallu-
cinations were used in the current study. These subscales have high
internal consistency (Cronbach's alpha 0.93 for paranoia, 0.87 for hal-
lucinations), and have been used in clinical and non-clinical groups
(Ronald et al., 2014; Zavos et al., 2014). The paranoia subscale contains
15 items, and the hallucinations subscale contains 9 items, both as-
sessing the frequencies of each psychotic experience over the past
month. Items are rated on a 0–5 Likert scale (where 0 is “Not at all”, and
5 is “Nearly all the time”), therefore the maximum score for paranoia is
75 and the maximum score for hallucinations is 45.
2.2.3. Negative aﬀect
Depression and anxiety were assessed using the relevant two sub-
scales from the 21-item Depression Anxiety Stress scale (DASS;
Lovibond and Lovibond, 1995). The DASS is widely used and well-va-
lidated in clinical groups, with high internal consistency (Cronbach's
alpha 0.94 for depression, 0.87 for anxiety) In this questionnaire there
are seven items indexing each of depression and anxiety, all rated on a
0–3 Likert scale where 0 is “Did not apply to me” and 3 is “Applied to
me very much or nearly all the time”, therefore the maximum score for
depression or anxiety is 21.
2.3. Analysis
All analysis was carried out in SPSS 23 (IBM Corp., 2015). The ﬁrst
step in the analysis was to examine descriptive statistics in order to
report on the levels of insomnia, paranoia, hallucinations, depression
and anxiety, and indicate if there were changes over the course of the
three-month observation period.
For all further analyses the study variables were transformed by
log10. This allows the estimated coeﬃcients and t-statistics to be com-
pared across analyses (Benoit, 2011; Box et al., 1964; Keene, 1995). The
coeﬃcient can be interpreted as a percentage contribution, such that if
the coeﬃcient of insomnia is 1.7 towards paranoia, this indicates that a
1% increase in insomnia is associated with a 1.7% increase in paranoia.
Prior to log transformation 1 was added to all scores to preserve 0
scores in the raw data (log10(1) is 0, whereas log10(0) is incalculable as
it tends to negative inﬁnity).
2.3.1. Phase 1: cross-sectional association
In this phase, cross-sectional associations were tested between in-
somnia, negative aﬀect (i.e. depression and anxiety) and psychotic ex-
periences (i.e. paranoia and hallucinations), with the hypothesis being
that all study variables are signiﬁcantly associated within each time
point. Multi-level mixed eﬀect models were used, allowing these tests to
be nested within each individual and within each time point. Fixed
eﬀects were assumed in these and all subsequent multi-level mixed
eﬀect models, with random eﬀects used to account for repeated mea-
sures from the same participant.
2.3.2. Phase 2: longitudinal mediation
In this phase the second and third hypotheses were tested by ap-
plying a series of mixed eﬀect models to longitudinal data. The second
hypothesis was tested by examining the signiﬁcance of the predictive
relationship from insomnia to later psychotic experiences. The third
hypothesis was addressed by comparing the ﬁt of a hypothesised model
(where insomnia is the predictor, and depression or anxiety was the
mediator) to an opposition model (where anxiety or depression was the
predictor, and insomnia was the mediator) with psychotic experiences
(paranoia or hallucinations) as the outcome variable. See Fig. 2 for an
outline of these pathways. In all cases the predictor was taken from the
previous time point (t−1), and the mediator and outcome were taken
from the current time point (t), amalgamating the three time points into
two parallel longitudinal comparisons.
Model ﬁt was compared by using the Bayesian Information Criterion
(BIC). This provides a measure of model ﬁt to the observed data, with a
penalty function applied for lower parsimony. The BIC value can be
compared across diﬀerent models which are modelling the same out-
come, with a lower BIC indicating that the model is a better ﬁt to the
observed data. Therefore the hypothesised models were expected to
have a lower BIC value than the oppositional models. Comparison be-
tween models can be achieved by using threshold values of diﬀerences
between BICs, with diﬀerences greater than 5 and greater than 10 in-
dicating strong or very strong support for a signiﬁcant diﬀerence be-
tween the two models (Kass and Raftery, 1995).
Mediation was estimated using the Baron and Kenny method
(Baron and Kenny, 1986). In this method the relationship between
predictor and outcome (e.g. insomnia and paranoia) is estimated to give
the total eﬀect (Path C). The relationship between the predictor and
hypothesised mediator (e.g. insomnia to anxiety) is estimated (Path A).
Finally, the relationship between predictor and outcome (e.g. insomnia
to paranoia) is estimated, with the addition of the mediator (e.g. an-
xiety) to the model. This gives the estimate for Path B (from the med-
iator to the outcome) and Path C’ (from predictor to outcome when
controlling for the mediator). See Fig. 2 for a diagram of this process.
The proportion of mediation is calculated as the ratio of the indirect
eﬀect (the product of Path A and Path B) to the total eﬀect. Proportions
greater than 100% indicate that the mediator has an independent re-
lationship with the outcome in addition to its role as a mediator in the
given model. This proportion was compared in the hypothesised and
oppositional models, with the expectation that hypothesised models
show a higher proportion of mediation than oppositional models.
2.3.3. Phase 3: directional comparison
Finally, a comparison was made of the predictive value for insomnia
to later paranoia or hallucinations versus the predictive value for
paranoia or hallucinations to later insomnia in order to address hy-
potheses four and ﬁve.
Another set of mixed eﬀects models were ﬁtted, again with hy-
pothesised models compared against oppositional models. A diagram of
this analysis process can be found in Fig. 3. First, univariate models
were ﬁtted with current insomnia, previous insomnia (Model 2 in the
ﬁgure), and previous paranoia as factors predicting current paranoia.
Following this previous paranoia and previous insomnia were tested as
predictors of current paranoia in the same model (Model 4 in the
ﬁgure). This allows examination of the contribution of previous in-
somnia to predicting change in paranoia by controlling for the inﬂuence
of previous paranoia on later paranoia. The oppositional model was
then constructed (in this case with paranoia as a predictor of insomnia)
to compare to the hypothesised model. The same process was then re-
peated for insomnia and hallucinations.
Hypothesis four predicted that the psychotic experiences would
signiﬁcantly predict later insomnia, which is tested in the oppositional
models at this phase. Hypothesis ﬁve was then addressed by comparing
the hypothesised and oppositional models. It was not possible to use the
BIC for comparison as the outcome variable diﬀered between models,
but the p-values, t-statistics, and estimated coeﬃcients were instead
used to compare the strength of the associations in each model.
3. Results
3.1. Demographic and descriptive statistics
Demographic statistics can be found in Table 1. The study group had
a slight majority of female participants (n=16, 55.2%). The majority
of participants were patients within an early intervention in psychosis
service (n=21, 72.4%), and the majority were prescribed anti-
psychotic medication (n=21, 72.4%).
Descriptive statistics for the study measures are displayed in
Table 2. There was high retention within the study, with 89.1%
(n=26) and 96.6% (n=28) of participants completing the one and
three-month follow-up assessments. Severity of all symptoms decreased
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over the observation period, with the largest decreases seen in anxiety,
(48.3% reduction from baseline to three months), hallucinations
(19.8%), and paranoia (17.6%).
3.2. Phase one: cross-sectional associations
The results of the cross-sectional analysis can be seen in Table 3. In
the univariate models, current insomnia, anxiety, and depression were
all signiﬁcantly positively associated with current paranoia
(p<0.001). Current insomnia, anxiety and depression were also sig-
niﬁcantly positively associated with increased hallucinations
(p<0.001). Current insomnia was signiﬁcantly associated with anxiety
and depression (p<0.001). In summary, all the factors (insomnia,
anxiety, and depression) were signiﬁcantly cross-sectionally associated
with each other, as predicted by the ﬁrst hypothesis.
3.3. Phase two: longitudinal mediation analysis
Table 4 contains results from the longitudinal analysis, investigating
the hypothesised ‘insomnia to negative aﬀect to paranoia’ pathway,
compared with an oppositional ‘negative aﬀect to insomnia to paranoia’
pathway. All total eﬀect pathways were signiﬁcant (i.e. previous in-
somnia, anxiety and depression were all signiﬁcantly associated with
later paranoia). The indirect pathway section shows that, while all re-
lationships were highly signiﬁcant, the estimated coeﬃcients for the
hypothesised models were higher than in the oppositional models. For
example, a 1% increase in insomnia resulted in a 2% increase in later
depression, whereas a 1% increase in depression resulted in a 0.2%
increase in later insomnia. The ﬁnal section of the table illustrates the
competing possibilities for mediation. The BIC values show that the
hypothesised models where insomnia is prior were a better ﬁt to the
data (BICs of 66.8 and 45.6) than models where anxiety or depression
are prior (BICs of 86.1 and 83.6), with the size of the diﬀerences
(both>10) provide ‘very strong’ support for a signiﬁcant diﬀerence
between the models in both cases (Kass and Raftery, 1995). The
mediated portion of the eﬀect was higher in the hypothesised models
than in the oppositional models.
Table 5 shows the results for hallucinations from this analysis. In-
somnia, anxiety, and depression severity were all individually sig-
niﬁcant predictors of later hallucinations. However, as with paranoia,
in the mediation models it was clear that the models with insomnia as
predictor and negative aﬀect as mediator (BICs of 70.2 and 79.5) pro-
vided a better ﬁt to the observed data than the oppositional models
(BICs of 91.6 and 88.4). The model comparison for insomnia and an-
xiety indicates ‘very strong’ support for a signiﬁcant diﬀerence (BIC
diﬀerence= 21.2), while the model comparison for insomnia and
Fig. 2. Longitudinal mediation analysis process diagram (phase two).
Fig. 3. Longitudinal directional analysis process diagram (phase three).
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depression indicates `strong’ support (BIC diﬀerence= 8.9; Kass and
Raftery, 1995) . Furthermore, a higher proportion of eﬀect was medi-
ated in the hypothesised models than in the oppositional models. The
hypothesised models for paranoia mediated a higher proportion of the
relationship than the hypothesised models for hallucinations, indicating
that negative aﬀect has a greater mediator role for insomnia leading to
paranoia than insomnia and hallucinations.
In summary, insomnia was a signiﬁcant predictor of later paranoia
and later hallucinations, supporting our second hypothesis. The third
hypothesis was also supported; models where insomnia was the pre-
dictor and negative aﬀect was the mediator were a better ﬁt than op-
positional models where these roles were reversed.
3.4. Phase three: comparing direction of eﬀects
Table 6 contains results comparing the prediction of insomnia by
paranoia versus prediction of paranoia by insomnia. Both insomnia and
paranoia signiﬁcantly predicted each other over time. However, the t-
statistics between Models 1, 2, and 4 for each direction did show dif-
ferences. For Model 1 (cross-sectional), the insomnia to paranoia di-
rection had a higher t-value than the reverse direction (5.06 compared
to 4.23), indicating this has the highest eﬀect. Moving to Model 2,
which tested longitudinal prediction, the direction from paranoia to
insomnia instead had the highest t-statistic by a small margin (3.53
versus 3.09 for the hypothesised model). For Model 4, where the model
was adjusted for the previous level of the outcome, the oppositional
model again had a higher t statistic, although again the margin was
small (1.07, versus 0.97 for the hypothesised model). This supports a
bidirectional relationship between insomnia and paranoia, as the dif-
ferences in t-statistics between the hypothesised and oppositional
models are not large enough to be signiﬁcant (all diﬀerences are less
than 1, which is the standard deviation of the t distribution).
Table 7 contains the results from the same analysis for insomnia and
hallucinations. Cross-sectionally (Model 1) hallucinations were slightly
more predictive of insomnia than vice versa (t=2.94 vs t=3.23).
However, in both longitudinal analyses (Models 2 and 4) the hy-
pothesised models (t=2.14, t=1.25) with insomnia as prior show a
stronger eﬀect than the oppositional models (t=1.68, t=1.00). As
with paranoia, these diﬀerences in t statistics are not large enough to be
considered signiﬁcant. However, the uncorrected oppositional model
(Model 2) indicated that previous hallucinations was itself not a sig-
niﬁcant predictor (p=0.085) for later insomnia in this study. Overall
these results therefore support that insomnia was a stronger predictor of
hallucinations than vice versa.
In summary the fourth hypothesis regarding a role of psychotic
experiences in predicting insomnia was partially supported: paranoia
signiﬁcantly predicted later insomnia, but hallucinations did not clearly
predict later insomnia in our results. The ﬁnal hypothesis – that the
insomnia to psychotic experience relationship would be stronger than
the reverse direction – was also partially supported. The insomnia to
hallucinations relationship appeared stronger than the reverse direc-
tion, but the relationship between insomnia and paranoia was bidir-
ectional.
4. Discussion
This was the ﬁrst longitudinal study to investigate clinical trends in
insomnia and psychotic symptoms over a number of months in patients
with early non-aﬀective psychosis. The results support the key hy-
potheses that insomnia is a signiﬁcant predictor of paranoia and hal-
lucinations both within and across time, with the relationships medi-
ated by negative aﬀect (depression and anxiety). This is especially the
Table 1
Demographic statistics of study sample.
Demographic Value
Age - mean (SD) 23.55 (3.8)
Gender – n (%)
Male 13 (44.8)
Female 16 (55.2)
Living status – n (%)
With parents or other relatives 15 (51.7)
Alone 5 (17.2)
With spouse/partner 5 (17.2)
Other (e.g. shared accommodation) 4 (13.8)
Antipsychotic Medication
Prescribed antipsychotic medication - n (%) 21 (72.4)
DDD - mean (SD)a 0.81 (0.4)
Mental health team type – n (%)
EIS 21 (72.4)
AMHT 8 (27.6)
NHS Trust – n (%)
OHFT 20 (69.0)
CNWL 8 (27.6)
BHFT 1 (3.4)
Ethnicity/Citizenship – n (%)
White/White British 15 (51.7)
Asian/Asian British 5 (17.2)
Black/African/Caribbean/Black British 3 (10.3)
Mixed or multiple ethnic background 6 (20.7)
AMHT=Adult Mental Health Team; DDD=Deﬁned Daily Dose; EIS= Early
Intervention in Psychosis Service; OHFT=Oxford Heath NHS Foundation
Trust; CNWL=Central and Northwest London NHS Foundation Trust;
BHFT=Berkshire Healthcare NHS Foundation Trust.
a DDD average excludes the eight participants not prescribed antipsychotic
medication at time of participation.
Table 2
Descriptive statistics of study measures across time points.
Baseline
(n=29)
1 month
(n=26)
3 months
(n=28)
Mean (SD) Mean (SD) Mean (SD)
Insomnia (Sleep-50) 21.45 (6.3) 20.58 (6.4) 18.68 (6.4)
Paranoia (SPEQ) 38.72 (23.5) 34.08 (24.1) 31.89 (24.1)
Hallucinations (SPEQ) 18.07 (12.8) 15.58 (11.9) 14.50 (14.0)
Depression (DASS) 9.69 (5.5) 9.81 (7.7) 8.75 (7.3)
Anxiety (DASS) 12.31 (6.3) 8.50 (5.8) 6.36 (4.4)
SPEQ=Speciﬁc Psychotic Experiences Questionnaire; DASS=Depression
Anxiety Stress Scale.
Table 3
Associations between insomnia, psychotic experiences, and negative aﬀect (cross-sectional analysis).
Factors Outcome BIC Beta Std. Error df t p 95% CI
Insomnia Paranoia 138.0 2.073 0.41 80.1 5.10 <0.001 1.2, 2.9
Anxiety Paranoia 100.0 1.154 0.12 77.0 9.84 <0.001 0.9, 1.4
Depression Paranoia 74.9 1.118 0.09 67.9 12.67 <0.001 0.9, 1.3
Insomnia Hallucinations 147.3 1.278 0.43 80.0 2.97 0.004 0.4, 2.1
Anxiety Hallucinations 118.8 0.940 0.13 77.9 7.12 <0.001 0.7, 1.2
Depression Hallucinations 124.3 0.783 0.12 69.8 6.40 <0.001 0.5, 1.0
Insomnia Anxiety 39.5 1.787 0.22 77.7 8.14 <0.001 1.3, 2.2
Insomnia Depression 52.6 1.819 0.23 64.9 7.98 <0.001 1.4, 2.3
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case for paranoia, where negative aﬀect completely mediated the eﬀect
of insomnia on paranoia, whereas only partial mediation was demon-
strated for hallucinations. A novel ﬁnding is that paranoia was also a
signiﬁcant predictor of later insomnia, supporting a conceptualization
of a bidirectional relationship. However, the relationship between in-
somnia and hallucinations appears to move more strongly in one di-
rection – from insomnia to hallucinations – than in the reverse direc-
tion. These ﬁndings clearly endorse the importance of insomnia as a
factor in the maintenance of paranoia and hallucinations, while also
providing further detail on the interaction between these symptoms.
These ﬁndings support a role for negative aﬀect as mediating the
relationship between insomnia and psychotic experiences as found in a
recent non-clinical manipulation study (Reeve et al., 2018). This is also
consistent with well-known links between insomnia and negative aﬀect,
and also with the importance of aﬀective processes in theoretical
models of psychotic experiences (Freeman and Garety, 2003). It is in-
teresting that negative aﬀect mediated a larger proportion of the
relationship between insomnia and paranoia than insomnia and hallu-
cinations. This has been reported elsewhere (Reeve et al., 2018), and is
consistent with a larger evidence base for the role of anxiety and de-
pression in paranoia than in hallucinations (Hartley et al., 2013). Fur-
thermore, the results here indicate that treatment of insomnia would be
likely to improve aﬀective symptoms, which besides their role in psy-
chotic experiences, are additionally associated with signiﬁcant distress
and disability (Koyanagi et al., 2017, 2016).
The results of this study have clinical implications regarding the
importance of treating insomnia in people with psychosis, even more so
given that the inﬂuence of psychotic experiences on insomnia was taken
into account. The ﬁnding that paranoia also increases insomnia high-
lights the importance of targeting both paranoia and insomnia in this
group – if treating insomnia improves paranoia, and paranoia improves
insomnia, it is possible that treatment for one factor might instil a
virtuous cycle of symptom improvement for both issues. For halluci-
nations, the ﬁnding that insomnia severity predicts later hallucination
Table 4
Insomnia, anxiety and depression as predictors vs mediators of paranoia.
Factors Outcome BIC Beta Std. Error df t p 95% CI Indirect
eﬀect
(A*B)
Total
eﬀect
(C)
Proportion
mediated
(%)
Total eﬀect (Path C)
t−1 insomnia paranoia 95.3 1.826 0.59 50.0 3.11 0.003 0.6, 3.0
t−1 anxiety paranoia 94.4 0.748 0.20 48.2 3.74 0.001 0.3, 1.2
t−1 depression paranoia 91.4 0.839 0.20 45.8 4.20 <0.001 0.4, 1.2
Indirect eﬀect (Path A)
t−1 insomnia anxiety 27.4 1.511 0.30 48.32 5.04 <0.001 0.9, 2.1
t−1 insomnia depression 60.2 2.019 0.41 49.77 4.92 <0.001 1.2, 2.8
t−1 anxiety insomnia −56.0 0.191 0.04 49.7 4.78 <0.001 0.1, 0.3
t−1 depression insomnia −55.2 0.187 0.05 42.86 3.74 <0.001 0.1, 0.3
Mediation models (Path B, Path C’)
t−1 insomnia (predictor) paranoia 66.8 −0.144 0.53 44.6 −0.27 0.788 −1.2, 0.9 2.079 1.826 113.9a
anxiety (mediator) 1.376 0.21 48.4 6.55 <0.001 1.0, 1.8
t−1 insomnia (predictor) paranoia 45.6 −0.461 0.43 48.2 −1.08 0.286 −1.3, 0.4 2.302 1.826 126.1a
depression (mediator) 1.140 0.12 48.5 9.49 <0.001 0.9, 1.4
t−1 anxiety (predictor) paranoia 86.1 0.361 0.22 48.5 1.63 0.109 −0.1, 0.8 0.349 0.748 46.7
insomnia (mediator) 1.826 0.59 48.5 3.07 0.004 0.6, 3.0
t−1 depression (predictor) paranoia 83.6 0.488 0.21 38.8 2.35 0.026 0.1, 0.9 0.311 0.839 37.1
insomnia (mediator) 1.663 0.58 48.8 2.89 0.006 0.5, 2.8
t−1= previous time point.
a Proportions over 100 indicate an independent relationship of the mediator on to the outcome, separate from its role in mediating the eﬀect of the predictor.
Table 5
Insomnia, anxiety, and depression as predictors vs mediators of hallucinations.
Factors Outcome BIC Beta Std. Error df t p 95% CI Indirect eﬀect
(A*B)
Total eﬀect
(C)
Proportion mediated
(%)
Total eﬀect (Path C)
t−1 insomnia hallucinations 95.9 1.262 0.59 49.3 2.14 0.038 0.1, 2.1
t−1 anxiety hallucinations 96.6 0.446 0.21 48.8 2.13 0.035 0.0, 0.9
t−1 depression hallucinations 91.9 0.644 0.20 45.1 3.20 0.003 0.2, 1.0
Indirect eﬀect (Path A)
t−1 insomnia anxiety 27.4 1.511 0.30 48.32 5.04 <0.001 0.9, 2.1
t−1 insomnia depression 60.2 2.019 0.41 49.77 4.92 <0.001 1.2, 2.8
t−1 anxiety insomnia −56.0 0.191 0.04 49.7 4.78 <0.001 0.1, 0.3
t−1 depression insomnia −55.2 0.187 0.05 42.86 3.74 <0.001 0.1, 0.3
Mediation models (Path B, Path C’)
t−1 insomnia (predictor) hallucinations 70.2 −0.954 0.56 45.9 −1.72 0.093 −2.1, 0.2 0.870 1.081 80.5
anxiety (mediator) 1.236 0.21 41.2 5.90 <0.001 0.8, 1.7
t−1 insomnia (predictor) hallucinations 79.5 −0.546 0.59 43.1 −0.93 0.347 −1.7, 0.7 0.779 1.081 72.1
depression (mediator) 0.777 0.17 43.9 4.59 <0.001 0.4, 1.1
t−1 anxiety (predictor) hallucinations 91.6 0.210 0.23 48.9 0.90 0.374 −0.3, 0.7 0.230 0.466 49.4
insomnia (mediator) 1.309 0.63 49.0 2.08 0.043 0.0, 2.6
t−1 depression (predictor) hallucinations 88.4 0.462 0.23 41.8 2.02 0.048 0.0, 0.9 0.186 0.644 28.9
insomnia (mediator) 0.997 0.61 49.0 1.65 0.106 −0.2, 2.2
t−1= previous time point.
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severity but not vice versa supports a potential role for insomnia
treatment in improvement of hallucination severity. The results there-
fore support a role of treating insomnia to improve psychotic experi-
ences (Freeman et al., 2017).
A recent survey found that clinicians rarely utilise formal assess-
ments or recommended interventions for sleep disorders
(Rehman et al., 2016). Yet the feasibility, acceptability, and eﬀective-
ness of cognitive behavioural therapy for insomnia, with appropriate
adaptations, has been demonstrated for patients with persistent psy-
chosis (Freeman et al., 2015; Waite et al., 2016b), individuals at-risk of
psychosis (Bradley et al., 2018), and inpatients (Sheaves et al., 2017).
In all these studies, improvements in insomnia were large (d≥ 0.9),
and uptake of treatment was high (96% across the three trials listed). As
discussed earlier, cognitive behavioural therapy for insomnia has also
been shown to improve non-clinical psychotic experiences, and nega-
tive aﬀect, in students with insomnia (Freeman et al., 2017). These
recent advances, alongside the current study, indicate that the treat-
ment of insomnia should be given a higher priority in mental health
services.
4.1. Limitations and conclusion
One limitation is that it is not possible to tell if the study group is
representative of the participant population in general – it may be that
those with insomnia were more likely to take part in the study and
attend follow up appointments, potentially inﬂating the relationships
reported here. However, this potential bias was minimised wherever
possible by pro-active approaches for follow-up and ﬂexibility in as-
sessments, as demonstrated by the high retention rate within the study.
It is also worth noting that all participants in the study were currently
receiving care within mental health services (with the majority pre-
scribed antipsychotic medication).
A generic limitation of longitudinal observational studies is the as-
sumption that priority is suggestive of a causal role, as it could be the
case that insomnia (or anxiety and depression) might be more readily
acknowledged by the participants than psychotic experience. In this
case evidence of prior occurrence could be an artefact of a lower
threshold for awareness of the issue. However, in this study all out-
comes were assessed at each time point using the same questionnaires,
therefore it is diﬃcult to see how the threshold for acknowledging
symptoms would change over the course of the study, especially when
the general trend was for improvement in symptoms. Another general
issue with longitudinal observational studies is that a common cause
cannot be ruled out as the key explanatory factor.
In conclusion, this study provides evidence that insomnia symptoms
are predictive of changes in psychotic experiences in an early psychosis
clinical group, with this relationship strongly mediated by insomnia
predicting later negative aﬀect. Importantly, this study is the ﬁrst to
indicate that the predictive relationship from insomnia to psychotic
experiences has the same or greater strength than the reverse re-
lationship in a clinical group, prompting a rethink of traditional con-
ceptualisations of insomnia as a secondary concern in psychosis.
Furthermore, given the existence of an eﬀective insomnia intervention
for this group (CBTi; Freeman et al., 2015), these results strongly sup-
port further research investigating if treating insomnia improves clin-
ical trajectory for individuals with early psychosis.
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